why choose us

First received: March 16, 2023

Clinical Trial: Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia

Study Status: Completed

Recruit Status: RECRUITING

Condition: High Triglycerides

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 28- Day Phase II Proof of Concept Study to Evaluate the Efficacy and Safety of NST-1024 400 mg BID Versus Placebo in Statin-Naïve or Statin-

Brief Summary: This is a Phase IIa,multicentre proof of concept study consisting of 2 study periods to study Treatment with NST-1024 as an adjunct to diet to reduce triglyceride (TG) levels in subjects with TG levels of ?500 mg/dL and ?2000 mg/dL; determined by percentage change in TG from baseline after 28 days of treatment.The two periods consist of:A 3-week screening period that includes a TG qualifying period, andA 28-days, double-blind, randomized, parallel group, placebo-controlled treatment period.Subjects will…

Read more